Molbio Diagnostics Limited (MOLBIO) Share Price

NSE · Healthcare · Medical Devices · ISIN INE869T01028

₹1,107.80+54.50 (+5.17%)

Key metrics

Market Cap
₹12,138 Cr
P/E Ratio
72.89
EPS
14.45
Book Value
P/B Ratio
ROE
12.73%
ROCE
15.86%
Debt / Equity
0.34
Net Margin
11.77%
Revenue Growth
41.85%
Profit Growth
14.81%
Dividend Yield
52W High
₹1,264.60
52W Low
₹926.35
Market Cap Band
mid cap
Face Value

Ratios computed from the annual results period ending 2026-03-31.

About Molbio Diagnostics Limited

Molbio Diagnostics Limited, a point-of-care diagnostics company, provides healthcare technologies to diagnose infectious and non-communicable diseases. It manufactures and sells chip based diagnostic devices, chips and reagents, X-ray equipment's, and single/dual detectors. It also offers disposable POCT devices, which includes dengue, malaria, and COVID-19 tests; Tabletop analysers, a portable machine that are used to perform molecular or immunodiagnostic tests to detect infectious diseases, such as tuberculosis, human papillomavrus, STIs, and GI disorders. In addition, the company offers Truenat, a multi-disease real-time polymerase chain reaction platform that enables treatment decisions for various infectious and non-communicable diseases, such as tuberculosis, human immunodeficiency virus, malaria, viral hepatitis, COVID-19, dengue, chikungunya, influenza, H1N1, HPV/cervical cancer, cholera, leprosy, etc.; and Truenat assays. The company was incorporated in 2000 and is based in Verna, India.

Headquarters
Verna, India
Employees
1,225
Promoter Holding
83.41%

The full Molbio Diagnostics Limited analysis

Create a free account to open the complete MOLBIO deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.

  • 10-year financialsIncome statement, balance sheet and cash flow, year by year.
  • Valuation & fair valueFair-value estimates, quality scores and a value grade.
  • Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
  • Shareholding historyPromoter, FII, DII and public holdings across every quarter.
  • Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
  • Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.